(untitled) - Raison, C L; Rutherford, R E; Woolwine, B J (A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers JAMA Psychiatry, 2013)
et al.